Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07661758

Intravenous Lidocaine to Prevent Post-Fundal Pressure Headache During Cesarean Section

This prospective randomized controlled multicenter study will be conducted to evaluate the effects of pre-emptive IV lidocaine dose on the incidence and severity of intraoperative headache that may occur after the extra-abdominal manual uterine fundal pressure in patients undergoing cesarean section under spinal anesthesia.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year and older

Sex eligibility

Female

Study type

Interventional

Phase

Phase 3

Primary location

Tanta University Hospitals

Tanta, Gharbia Governorate, 31527, Egypt

Location status: Recruiting

Location contact

Osama M Rehab, MD

CONTACT

[email protected]

+201095210806

About this study

This fundal pressure was previously evaluated for its effect on maternal hemodynamics during cesarean section. The investigators observed in their practice that a complaint of headache is reported by a percentage of patients immediately after fundal pressure and fetal delivery. Despite its small percentage, it had a negative impact on the maternal experience.

The proposed mechanism of this headache may be attributed to the fundal pressure-induced cushing reflex, vasopressin response, or cerebral venous engorgement all resulted from the increase in intra-abdominal pressure which can be reflected on the intra-thoracic pressure and the intracranial pressure (ICP).

Lidocaine is a local anesthetic that, when given via intravenous (IV) route could attenuate the rise in ICP during tracheal suctioning, and decrease the optic nerve sheath diameter distension during endotracheal intubation and during laparoscopy. These effects could be established by reducing cerebral blood volume through its vasoconstrictive effects on the cerebral vasculature and by decreasing electrical activity and metabolic demands through its inhibitory effects on sodium channels.

The fundal pressure maneuver is supposed to produce pathophysiological changes that resemble the previously reported factors that led to ICP elevation (intubation and pneumo-peritoneum). So, this study will be conducted as the investigators hypothesize that the administration of single IV lidocaine dose shortly before uterine fundal pressure may attenuate the temporary rise in ICP which may decrease the incidence of headache.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Aged ≥ 18 years
  • American Society of Anesthesiologists (ASA) Physical Status II
  • Scheduled for elective cesarean section under spinal anesthesia

Exclusion criteria

  • Patients declined to participate in the trial,
  • Patients with history of any type of headache, mental illness, or cerebrovascular diseases
  • Previous epidural insertion for painless labor or any other indications;
  • Patients on opioid or analgesic medications;
  • Those with pregnancy-induced hypertension or diabetic patients,
  • Allergy to lidocaine;
  • Contraindication or failure of spinal anesthesia.

Treatment and study plan

Lidocaine IV

Drug

IV lidocaine 1.5 mg/kg (diluted with 0.9% isotonic saline to a total volume of 10 ml) over 5 minutes with the start of skin incision after ensuring negative baseline headache.

saline 0.9%

Other

IV 10 ml isotonic saline over 5 minutes with the start of skin incision after ensuring negative baseline headache.

Primary outcomes

  1. Incidence of intraoperative headache

    Time frame: Up to the end of surgery.

    The incidence of intraoperative headache that may occur after fundal pressure application until the end of surgery will be recorded.

Secondary outcomes

  1. Severity of intraoperative headache

    Time frame: Up to the end of surgery.

    The numerical rating scale (NRS) scores which is a 11-point scale ranging from 0= no pain to 10= most severe pain will be used to evaluate the severity of headache.

  2. The changes in optic nerve sheath diameter

    Time frame: Up to the end of surgery.

    Optic nerve sheath diameter will be assessed by ultrasound before spinal block, at skin incision, after fetal delivery, and at the end of surgery.

  3. Incidence of shoulder pain

    Time frame: Up to 24 hours after surgery.

    The incidence of shoulder pain that may occur intraoperatively and up to 24 hours after surgery will be recorded by asking the patients if they have any pain in their shoulder area. The numerical rating scale (NRS) scores which is a 11-point scale ranging from 0= no pain to 10= most severe pain will be used to evaluate the severity of shoulder pain.

  4. Neonatal Apgar (appearance, pulse, grimace, activity, and respiration) scores

    Time frame: Up to 5 minutes after delivery.

    Neonatal Apgar scores which include five signs (appearance, pulse, grimace, activity, and respiration) will be recorded at 1 min and 5 minutes after delivery. Each sign has a score of 0, 1, 2 with a total score of 10. Scores more than 6 indicate normal good health.

  5. side effects

    Time frame: Intraoperative up to 1 hour after surgery.

    Nausea and vomiting, hypotension and bradycardia will be recorded

  6. Incidence of postoperative headache

    Time frame: Up to 24 hours after surgery.

    The incidence of any headache that may occur from the end of surgery up to 24 hours after surgery will be recorded.

Study contacts

Contact information is provided by the study sponsor or research team.

Osama M Rehab, MD

CONTACT

[email protected]

+201095210806

Sponsors and collaborators

Lead sponsor

Tanta University

Other

Registry information

Official study title

Pre-emptive Single Intravenous Lidocaine Dose to Prevent Post-Fundal Pressure Headache During Cesarean Section: The LID-HEAD Multi-center Randomized Controlled Trial

Acronym: LID-HEAD

Important dates

Study start
2026
Primary completion
2026
Study completion
2026
First posted
Jun 22, 2026
Registry last updated
Jul 6, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.